Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease.
Kawa
K
K
Okamura
T
T
Yagi
K
K
Takeuchi
M
M
Nakayama
M
M
Inoue
M
M
D000328:Adult; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D009033:Culicidae / Q000276:immunology*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000276:immunology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D004854:Herpesvirus 4, Human / Q000502:physiology; D006801:Humans; D006967:Hypersensitivity / Q000150:complications*; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007299:Insect Bites and Stings / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology / Q000473:pathology* / Q000821:virology; D008232:Lymphoproliferative Disorders / Q000150:complications* / Q000276:immunology; D008297:Male; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000032:analysis; D012074:Remission Induction; D012867:Skin / Q000276:immunology / Q000473:pathology / Q000821:virology; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000473:pathology* / Q000821:virology; D014775:Virus Activation
D007166:Immunosuppressive Agents; D016692:Receptors, Antigen, T-Cell, gamma-delta; D016572:Cyclosporine